2014-04-04 14:55:02 - Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016 - a new market research report on companiesandmarkets.com
The Global Dermatophytic Onychomycosis Therapeutics market is to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong and promising pipeline. The Global Dermatophytic Onychomycosis Therapeutics market has also been witnessing an increased focus on combination therapies for the treatment of dermatophytic onychomycosis. However, the adverse side effects associated with drugs could pose a challenge to the growth of this market.
A current trend witnessed in the Global Dermatophytic Onychomycosis Therapeutics market is the use of combination therapies for treating dermatophytic onychomycosis. It has been found that a combination of topical and systemic treatment increases the cure rate when compared to the single therapy. A combination of
amorolfine nail lacquer and oral terbinafine is the most commonly used combination therapy. It has improved clinical efficiency and is more cost-effective than terbinafine alone. At times the combination of surgery and systemic and topical therapies are also used in treatment. Moreover, sometimes non-pharmacological approaches such as laser treatment; mechanical treatment is also used in combination with topical and systemic therapy. This trend will have a positive impact on the growth of the market.
The growth of the Global Dermatophytic Onychomycosis Therapeutics market is driven by several factors, the most important of which is the strong and promising pipeline of drugs that have disease-modifying properties and a better safety and efficacy profile.
One of the key challenges in the market is the risk of side effects associated with dermatophytic onychomycosis drugs. These side effects are hampering the acceptance of advanced drugs for the treatment of moderate to severe dermatophytic onychomycosis.
The key vendors dominating this market space are Anacor Pharmaceuticals Inc., Celtic Pharmaceutical Holdings L.P., Genelabs Technologies Inc., Hisamitsu Pharmaceutical Co. Inc., Janssen Biotech Inc., Mayne Pharma Ltd., Merck & Co. Inc., NanoBio Corp., Novartis International AG, Palau Pharma S.A., Pfizer Inc., Promius Pharma LLC , Stiefel laboratories Inc., Topica Pharmaceuticals Inc., Valeant Pharmaceuticals International
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.